What's happening
Live detector signal
Generated 19:58 ET
KPTI — Karyopharm Therapeutics Inc is down 8.6%, at 1.48, on $8.3M traded, 5.3× 20-day volume, 0.31× float rotation. Score 74. Primary driver: 31.2% float rotation. Supply intelligence: clean gap · 74.
Get alerts on $KPTI
Halts, resumptions, new filings, and updated reports — in your inbox within minutes of the event.
Free · one email per event, no digests or spam · unsubscribe anytime · joins real followers
Free float
18.0M
2026-02-19
Shares out
22.7M
latest detail
Market cap
$36.7M
at ref price
Short interest
54.6%
2026-08-31
Float rotation
0.31×
latest snapshot
20d dollar vol
$2.0M
baseline
Gap quality
clean gap · 74
live supply-pressure model
Supply factor
negative gap pressure
detector reason
Supply factor
meaningful float rotation
detector reason
Supply factor
high short interest
detector reason
Supply factor
nano-cap supply profile
detector reason
This estimates whether a gap is clean, squeeze-prone, mixed, or supply-heavy using float, float rotation, short interest, market cap, split risk, and live volume. Registered resale/ATM exhaustion is a planned deeper parser layer.
2026-09-11 14:55 ETSignalKaryopharm Therapeutics Inc is down 8.6%, at 1.48, on $8.3M traded, 5.3× 20-day volume, 0.31× float rotation. Score 74. Primary driver: 31.2% float rotation. Supply intelligence: clean gap · 74.
2026-09-118-KItem 1.01 — Entry into a material definitive agreement; Item 3.02 — Unregistered sales of equity securities +1 more SEC
2026-08-138-KItem 2.02 — Results of operations and financial condition; Item 9.01 — Financial statements and exhibits SEC
2026-06-14 06:30 ETFDA / ClinicalMenarini Group Reports Data from the Phase 3 SENTRY Trial of Selinexor (NEXPOVIO®) Plus Ruxolitinib in Myelofibrosis at The European Hematology Association (EHA) 2026 Congress News
2025-03-01 08:45 ETAnalyst RatingInternational Myeloma Foundation (IMF) Celebrates Myeloma Milestones for 2025 Myeloma Action Month News
2024-11-25 11:00 ETGeneralGlioblastoma Multiforme Treatment Market Size to Reach USD 5.68 Bn by 2033 News
2024-09-05 14:16 ETEarnings GuidanceDown -12.14% in 4 Weeks, Here's Why Karyopharm Therapeutics Looks Ripe for a Turnaround News
Latest detector signalscore 74